Peripheral Arterial Disease: An Underestimated Aspect of Menopause-related Cardiovascular Disease

Panagiotis Anagnostis¹, Dimitri P Mikhailidis², Ales Blinc^{3

4}, Mojca Jensterle^{2

5}, Mateja K Ježovnik⁶, Gerit-Holger Schernthaner⁷, Pier Luigi Antignani⁸, Katica Bajuk Studen^{2

9

4}, Miso Sabovic^{3

4}, Pavel Poredos^{3

4}

Affiliations

¹ Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London Medical School, University College London (UCL) and Department of Clinical Biochemistry, Royal Free Hospital Campus (UCL), London, UK.
³ Department of Vascular Disease, University Medical Centre, Ljubljana, Slovenia.
⁴ Faculty of Medicine, Department of Internal Medicine, University of Ljubljana, Slovenia.
⁵ Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia.
⁶ The University of Texas Health Science Center at Houston, Department of Advanced Cardiopulmonary Therapies and Transplantation, Houston, Texas, USA.
⁷ Department of Medicine 2, Division of Angiology, Medical University of Vienna, Vienna, Austria.
⁸ Vascular Centre Nuova Villa Claudia, Medical University of Vienna, Rome, Italy.
⁹ Department of Nuclear Medicine, University Medical Centre, Ljubljana, Slovenia.

Editorial

Panagiotis Anagnostis et al. Curr Vasc Pharmacol. 2024.

. 2024;22(2):153-154.

doi: 10.2174/0115701611295374231212110458.

¹ Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London Medical School, University College London (UCL) and Department of Clinical Biochemistry, Royal Free Hospital Campus (UCL), London, UK.
³ Department of Vascular Disease, University Medical Centre, Ljubljana, Slovenia.
⁴ Faculty of Medicine, Department of Internal Medicine, University of Ljubljana, Slovenia.
⁵ Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia.
⁶ The University of Texas Health Science Center at Houston, Department of Advanced Cardiopulmonary Therapies and Transplantation, Houston, Texas, USA.
⁷ Department of Medicine 2, Division of Angiology, Medical University of Vienna, Vienna, Austria.
⁸ Vascular Centre Nuova Villa Claudia, Medical University of Vienna, Rome, Italy.
⁹ Department of Nuclear Medicine, University Medical Centre, Ljubljana, Slovenia.

No abstract available

References

1. Papas T.; Management of peripheral arterial disease after menopause. Curr Vasc Pharmacol Epub ahead of print2023
1. Anagnostis P.; Mikhailidis D.P.; Blinc A.; The effect of menopause and menopausal hormone therapy on the risk of peripheral artery disease. Curr Vasc Pharmacol 2023,21(5),293-296 - DOI - PubMed
1. Poredoš P.; Schernthaner G.H.; Blinc A.; Endocrine disorders and peripheral arterial disease: A Series of Reviews. Curr Vasc Pharmacol 2023,21(3),147-148 - DOI - PubMed
1. Anagnostis P.; Bitzer J.; Cano A.; Menopause symptom management in women with dyslipidemias: An EMAS clinical guide. Maturitas 2020,135,82-88 - DOI - PubMed
1. Leal L.G.; Lopes M.A.; Batista M.L.; Physical exercise-induced myokines and muscle-adipose tissue crosstalk: A review of current knowledge and the implications for health and metabolic diseases. Front Physiol 2018,9,1307 - DOI - PubMed